Received May 19, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | UNK | — | — |
9 Month Old Received HEPLISAV-B; Initial report received on 08-May-2026. A nurse reported that a 9-month-old patient (race and ethnicity not reported) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No medical history or concomitant medications were reported. On 07-May-2026, the patient received an unknown dose of a hepatitis B vaccine [HEPLISAV-B (lot number, expiration date, NDC #, route, and site not reported). The patient was 9 months old. No other information was available. Company Comment: The company assessedd the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Medical History/Concurrent Conditions: No adverse event